Stealth BioTherapeutics (Stealth BioTherapeutics) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Change In Payables And Accrued Expense?

Stealth BioTherapeutics's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2022 was $0.00 Mil. It means Stealth BioTherapeutics's Accounts Payable & Accrued Expense stayed the same from Dec. 2021 to Mar. 2022 .

Stealth BioTherapeutics's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2021 was $-1.56 Mil. It means Stealth BioTherapeutics's Accounts Payable & Accrued Expense declined by $1.56 Mil from Dec. 2020 to Dec. 2021 .

Stealth BioTherapeutics Change In Payables And Accrued Expense Historical Data

The historical data trend for Stealth BioTherapeutics's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Change In Payables And Accrued Expense Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

8.20

4.05

-5.95

-7.67

-1.56

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Stealth BioTherapeutics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Stealth BioTherapeutics Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.